Nj State Employees Deferred Compensation Plan Ionis Pharmaceuticals Inc Transaction History
Nj State Employees Deferred Compensation Plan
- $789 Million
- Q2 2024
A detailed history of Nj State Employees Deferred Compensation Plan transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Nj State Employees Deferred Compensation Plan holds 42,000 shares of IONS stock, worth $1.7 Million. This represents 0.25% of its overall portfolio holdings.
Number of Shares
42,000
Previous 42,000
-0.0%
Holding current value
$1.7 Million
Previous $1.82 Million
9.95%
% of portfolio
0.25%
Previous 0.23%
Shares
7 transactions
Others Institutions Holding IONS
# of Institutions
389Shares Held
125MCall Options Held
2.25MPut Options Held
510K-
Vanguard Group Inc Valley Forge, PA13.8MShares$559 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD12.6MShares$510 Million0.38% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$417 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V88.26MShares$333 Million6.59% of portfolio
-
Wellington Management Group LLP Boston, MA6.57MShares$265 Million0.06% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $5.73B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...